Skip to main
BIOX

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions Corp demonstrates a positive outlook due to its established crop protection portfolio, which has shown robustness outside of Argentina, indicating strong growth potential amidst domestic challenges. The company’s management is optimistic about international opportunities, particularly for its HB4 wheat revenue anticipated in the United States, Brazil, and Australia, despite acknowledging the time required to ramp up revenues with new partnerships. Additionally, the strong performance of bio-protection products in the U.S. and Latin America, as well as the success of adjuvant sales in Brazil, provide further support for the company’s financial resilience and growth prospects.

Bears say

Bioceres Crop Solutions Corp has experienced significant revenue declines due to weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, compounded by lower contributions from HB4-related sales following a shift to a licensing-based business model. Specifically, Crop Nutrition revenues decreased by approximately 34% year-over-year, amounting to around $25 million, as pricing pressures and reduced corn acreage have impacted market performance. Additionally, revenues from Seed and Integrated products fell drastically by about 75% year-over-year to approximately $8 million, highlighting the challenges faced during the transition to a seed technology partnership.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.